5 biotech trends to follow in 2020

Biotech ended 2019 on a tear, buoyed by renewed dealmaking and unexpectedly positive trial results for several smaller companies.

But, entering an election year, the industry appears at a crossroads, where excitement over clinical breakthroughs like gene therapy meets intensifying questions over how well the industry is upholding its social contract.